|
|
|
|
|
Weekly Update
|
November 30, 2024 |
|
|
|
This week on JAMA+ AI, we delve into AI-driven advances in neurology devices, diabetic retinopathy detection, insomnia identification through social media posts, and machine learning's potential role in diagnosing visual dysfunction.
If you are interested in sending a presubmission inquiry, or have a question for the editors, we invite you to contact us at jama+ai@jamanetwork.org.
|
|
Viewpoint
JAMA
AI Devices in Neurology—Moving From Diagnosis to Prognosis
James M. Hillis, MBBS, DPhil; Edward R. Scheffer Cliff, MBBS, MPH; Kerstin N. Vokinger, MD, JD, PhD
Research Letter
JAMA Ophthalmology
Use of Artificial Intelligence–Based Detection of Diabetic Retinopathy in the US
Shreya A. Shah, BS; Jared T. Sokol, MD, MBA; Karen M. Wai, MD; et al
Original Investigation
JAMA Network Open
Outdoor Artificial Light at Night and Insomnia-Related Social Media Posts
Marselle A. Rasdall, MD; Chloe Cho, BS; Amy N. Stahl, AuD; et al
JAMA Ophthalmology
Primary Visual Pathway Changes in Individuals With Chronic Mild Traumatic Brain Injury
Sachin D. Shah, MD
VIDEO
 Q&A with Robert M. Califf, MD, Commissioner, FDA
|
|
|
|
|
|
|
Thank you for subscribing to JAMA Network email alerts. This message was sent to buiduytam1@gmail.com by updates@jamanetwork.org.
To sign up for additional alerts, or to unsubscribe, click here.
To ensure you always receive JAMA Network emails, add the email address updates@jamanetwork.org to your address book.
To unsubscribe by mail, contact:
JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.
|
      |
|
©2024 American Medical Association. All rights reserved.
|
|
|
|
|
